I A Global Asset Management Inc. Novo Nordisk A S Transaction History

I A Global Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$122.71 - $146.91 $418,195 - $500,669	3,408 Added 17.55%	22,831 $3.26 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $1.27 Million - $1.69 Million	-12,455 Reduced 39.07%	19,423 $2.49 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $2.21 Million - $2.66 Million	-25,193 Reduced 44.14%	31,878 $3.3 Million
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $5.19 Million - $11.4 Million	57,071 New	57,071 $5.19 Million

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $232B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of I A Global Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on I A Global Asset Management Inc. with notifications on news.